Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA6 | P23280 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13189984 | 0.89 | — | — | |
| SCHEMBL10001259 | 0.72 | RARA (0.34) | CA1CA2PTPN1 | |
| SCHEMBL4454021 | 0.65 | MEN1 (0.36) | — | |
| SCHEMBL3919468 | 0.60 | TP53 (0.31) | — | |
| SCHEMBL19561425 | 0.57 | CA1 (0.36) | CA1CA2CA4CA6 | |
| SCHEMBL23406084 | 0.57 | HTR2A (0.31) | — | |
| SCHEMBL15614938 | 0.57 | — | — | |
| SCHEMBL18733082 | 0.54 | CA1 (0.67) | CA1CA2CA4CA6PTPN1 | |
| Tetrabromocatechol SCHEMBL29382370 | 0.54 | CA1 (1.00) | CA1CA2CA4CA6PTPN1 | |
| Tetrabromocatechol SCHEMBL985158 | 0.54 | CA1 (1.00) | CA1CA2CA4CA6PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969628-B2 | Method for enriching a homogeneous catalyst from a process flow | EVONIK DEGUSSA GMBH (DE) | 2015-03-03 | — | — | US | disclosed |
| US-8969628-B2 | Method for enriching a homogeneous catalyst from a process flow | EVONIK DEGUSSA GMBH (DE) | 2015-03-03 | — | — | US | disclosed |
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | EVONIK OXENO GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | EVONIK OXENO GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046503-A1 | METHOD FOR ENRICHING A HOMOGENEOUS CATALYST FROM A PROCESS FLOW | PARG, PHOSPHO1, COG6 | CA1 1637/4885CA2 3091/4885CA4 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.